{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:54:50Z","timestamp":1789779290190,"version":"4.0.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["TL1 TR002531"],"award-info":[{"award-number":["TL1 TR002531"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["UL1 TR002529"],"award-info":[{"award-number":["UL1 TR002529"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lawrence Family Bone Disease Program of Texas"},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-16-1-0040"],"award-info":[{"award-number":["W81XWH-16-1-0040"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["BC150678P1"],"award-info":[{"award-number":["BC150678P1"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dive Into The Pink; Indiana University School of Medicine Center for Musculoskeletal Health; Peggy S. Throgmartin Endowment; Lawrence Family Bone Disease Program of Texas"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68522-0","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:24:10Z","timestamp":1768955050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low intensity vibration with zoledronate reduces musculoskeletal weakness and adiposity in estrogen deprived female mice"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-5117","authenticated-orcid":false,"given":"Gabriel M.","family":"Pagnotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutha K.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreemala","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Pattyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-5816","authenticated-orcid":false,"given":"Monte S.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8255-4497","authenticated-orcid":false,"given":"Aji F.","family":"Touray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-585X","authenticated-orcid":false,"given":"William R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0909-7999","authenticated-orcid":false,"given":"Clinton T.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid S.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7026-402X","authenticated-orcid":false,"given":"Theresa A.","family":"Guise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"68522_CR1","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","volume":"6","author":"LA Kingsley","year":"2007","unstructured":"Kingsley, L. A., Fournier, P. G., Chirgwin, J. M. & Guise, T. A. Molecular biology of bone metastasis. Mol. Cancer Ther. 6, 2609\u20132617 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"68522_CR2","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"68522_CR3","doi-asserted-by":"crossref","first-page":"djv048","DOI":"10.1093\/jnci\/djv048","volume":"107","author":"BA Kohler","year":"2015","unstructured":"Kohler, B. A. et al. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race\/ethnicity, poverty, and state. J. Natl. Cancer Inst. 107, djv048 (2015).","journal-title":"J. Natl. Cancer Inst."},{"key":"68522_CR4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1200\/JCO.1984.2.10.1102","volume":"2","author":"GM Clark","year":"1984","unstructured":"Clark, G. M., Osborne, C. K. & McGuire, W. L. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J. Clin. Oncol. 2, 1102\u20131109 (1984).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher, K. N., Guise, T. A. & McCauley, L. K. Cancer to bone: a fatal attraction. Nat. Rev. Cancer 11, 411\u2013425 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"68522_CR6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/8756-3282(91)90059-R","volume":"12","author":"M Tubiana-Hulin","year":"1991","unstructured":"Tubiana-Hulin, M. Incidence, prevalence and distribution of bone metastases. Bone 12, S9\u2013S10 (1991).","journal-title":"Bone"},{"key":"68522_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12307-011-0075-6","volume":"4","author":"JT Buijs","year":"2011","unstructured":"Buijs, J. T., Stayrook, K. R. & Guise, T. A. TGF-beta in the bone microenvironment: role in breast cancer metastases. Cancer Microenviron. 4, 261\u2013281 (2011).","journal-title":"Cancer Microenviron."},{"key":"68522_CR8","first-page":"40","volume":"77","author":"TA Guise","year":"1993","unstructured":"Guise, T. A., Yoneda, T., Yates, A. J. & Mundy, G. R. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro. J. Clin. Endocrinol. Metab. 77, 40\u201345 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68522_CR9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise, T. A. et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Invest. 98, 1544\u20131549 (1996).","journal-title":"J. Clin. Invest."},{"key":"68522_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11010-011-1170-1","volume":"363","author":"D Guo","year":"2012","unstructured":"Guo, D., Huang, J. & Gong, J. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. Mol. Cell Biochem. 363, 179\u2013190 (2012).","journal-title":"Mol. Cell Biochem."},{"key":"68522_CR11","doi-asserted-by":"crossref","unstructured":"Mohan, S. & Baylink, D. J. Bone growth factors. Clin. Orthop. Relat. Res. 263, 30\u201348 (1991).","DOI":"10.1097\/00003086-199102000-00004"},{"key":"68522_CR12","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1158\/0008-5472.CAN-11-1194","volume":"71","author":"D Javelaud","year":"2011","unstructured":"Javelaud, D. et al. TGF-beta\/SMAD\/GLI2 signaling axis in cancer progression and metastasis. Cancer Res. 71, 5606\u20135610 (2011).","journal-title":"Cancer Res."},{"key":"68522_CR13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman, G. D. Mechanisms of bone metastasis. N. Engl. J. Med. 350, 1655\u20131664 (2004).","journal-title":"N. Engl. J. Med."},{"key":"68522_CR14","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","volume":"326","author":"RR Love","year":"1992","unstructured":"Love, R. R. et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N. Engl. J. Med. 326, 852\u2013856 (1992).","journal-title":"N. Engl. J. Med."},{"key":"68522_CR15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher, B. et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N. Engl. J. Med. 320, 479\u2013484 (1989).","journal-title":"N. Engl. J. Med."},{"key":"68522_CR16","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","volume":"28","author":"HJ Burstein","year":"2010","unstructured":"Burstein, H. J. et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J. Clin. Oncol. 28, 3784\u20133796 (2010).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","volume":"95","author":"AK Shiau","year":"1998","unstructured":"Shiau, A. K. et al. The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927\u2013937 (1998).","journal-title":"Cell"},{"key":"68522_CR18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","volume":"28","author":"M Dowsett","year":"2010","unstructured":"Dowsett, M. et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J. Clin. Oncol. 28, 509\u2013518 (2010).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR19","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/endo.142.11.8547","volume":"142","author":"ER Simpson","year":"2001","unstructured":"Simpson, E. R. & Davis, S. R. Minireview: aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology 142, 4589\u20134594 (2001).","journal-title":"Endocrinology"},{"key":"68522_CR20","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","volume":"364","author":"PE Goss","year":"2011","unstructured":"Goss, P. E. et al. Exemestane for breast-cancer prevention in postmenopausal women. N. Engl. J. Med. 364, 2381\u20132391 (2011).","journal-title":"N. Engl. J. Med."},{"key":"68522_CR21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","volume":"25","author":"AS Coates","year":"2007","unstructured":"Coates, A. S. et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J. Clin. Oncol. 25, 486\u2013492 (2007).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR22","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1200\/JCO.2008.18.4184","volume":"26","author":"F Saad","year":"2008","unstructured":"Saad, F. et al. Cancer treatment-induced bone loss in breast and prostate cancer. J. Clin. Oncol. 26, 5465\u20135476 (2008).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/annonc\/mdp033","volume":"20","author":"M Rabaglio","year":"2009","unstructured":"Rabaglio, M. et al. Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Ann. Oncol. 20, 1489\u20131498 (2009).","journal-title":"Ann. Oncol."},{"key":"68522_CR24","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/en.2004-1211","volume":"146","author":"A Schneider","year":"2005","unstructured":"Schneider, A. et al. Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology 146, 1727\u20131736 (2005).","journal-title":"Endocrinology"},{"key":"68522_CR25","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1073\/pnas.0711074105","volume":"105","author":"AM Bellinger","year":"2008","unstructured":"Bellinger, A. M. et al. Remodeling of ryanodine receptor complex causes \u201cleaky\u201d channels: a molecular mechanism for decreased exercise capacity. Proc. Natl. Acad. Sci. USA 105, 2198\u20132202 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68522_CR26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cmet.2011.05.014","volume":"14","author":"DC Andersson","year":"2011","unstructured":"Andersson, D. C. et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 14, 196\u2013207 (2011).","journal-title":"Cell Metab."},{"key":"68522_CR27","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","volume":"21","author":"DL Waning","year":"2015","unstructured":"Waning, D. L. et al. Excess TGF-beta mediates muscle weakness associated with bone metastases in mice. Nat. Med. 21, 1262\u20131271 (2015).","journal-title":"Nat. Med."},{"key":"68522_CR28","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1016\/S0021-9258(19)85166-9","volume":"268","author":"PS McPherson","year":"1993","unstructured":"McPherson, P. S. & Campbell, K. P. The ryanodine receptor\/Ca2+ release channel. J. Biol. Chem. 268, 13765\u201313768 (1993).","journal-title":"J. Biol. Chem."},{"key":"68522_CR29","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1359\/jbmr.2005.20.12.2274","volume":"20","author":"PJ Bekker","year":"2005","unstructured":"Bekker, P. J. et al. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004. J. Bone Min. Res. 20, 2275\u20132282 (2005).","journal-title":"J. Bone Min. Res."},{"key":"68522_CR30","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2007.11.8604","volume":"25","author":"A Lipton","year":"2007","unstructured":"Lipton, A. et al. Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases. J. Clin. Oncol. 25, 4431\u20134437 (2007).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","volume":"386","author":"M Gnant","year":"2015","unstructured":"Gnant, M. et al. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 386, 433\u2013443 (2015).","journal-title":"Lancet"},{"key":"68522_CR32","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/1078-0432.CCR-13-1246","volume":"20","author":"PD Ottewell","year":"2014","unstructured":"Ottewell, P. D. et al. Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo. Clin. Cancer Res. 20, 2922\u20132932 (2014).","journal-title":"Clin. Cancer Res."},{"key":"68522_CR33","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes, D. E. et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Min. Res. 10, 1478\u20131487 (1995).","journal-title":"J. Bone Min. Res."},{"key":"68522_CR34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1054\/bjoc.2001.1727","volume":"84","author":"SP Jagdev","year":"2001","unstructured":"Jagdev, S. P., Coleman, R. E., Shipman, C. M., Rostami, H. A. & Croucher, P. I. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. Br. J. Cancer 84, 1126\u20131134 (2001).","journal-title":"Br. J. Cancer"},{"key":"68522_CR35","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1054\/bjoc.1999.1131","volume":"82","author":"SG Senaratne","year":"2000","unstructured":"Senaratne, S. G., Pirianov, G., Mansi, J. L., Arnett, T. R. & Colston, K. W. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br. J. Cancer 82, 1459\u20131468 (2000).","journal-title":"Br. J. Cancer"},{"key":"68522_CR36","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/annonc\/mdq699","volume":"22","author":"A Lintermans","year":"2011","unstructured":"Lintermans, A. et al. Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis. Ann. Oncol. 22, 1763\u20131769 (2011).","journal-title":"Ann. Oncol."},{"key":"68522_CR37","first-page":"1401","volume":"22","author":"NL Henry","year":"2008","unstructured":"Henry, N. L., Giles, J. T. & Stearns, V. Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. Oncology 22, 1401\u20131408 (2008).","journal-title":"Oncology"},{"key":"68522_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i1.20","volume":"19","author":"SA Brown","year":"2009","unstructured":"Brown, S. A. & Guise, T. A. Cancer treatment-related bone disease. Crit. Rev. Eukaryot. Gene Expr. 19, 47\u201360 (2009).","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"68522_CR39","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2001.19.10.2767","volume":"19","author":"PP Donnellan","year":"2001","unstructured":"Donnellan, P. P., Douglas, S. L., Cameron, D. A. & Leonard, R. C. Aromatase inhibitors and arthralgia. J. Clin. Oncol. 19, 2767 (2001).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.2011.38.0261","volume":"30","author":"NL Henry","year":"2012","unstructured":"Henry, N. L. et al. Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J. Clin. Oncol. 30, 936\u2013942 (2012).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","volume":"111","author":"NL Henry","year":"2008","unstructured":"Henry, N. L. et al. Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res. Treat. 111, 365\u2013372 (2008).","journal-title":"Breast Cancer Res. Treat."},{"key":"68522_CR42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-011-1351-3","volume":"126","author":"SF Dent","year":"2011","unstructured":"Dent, S. F., Gaspo, R., Kissner, M. & Pritchard, K. I. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res. Treat. 126, 295\u2013310 (2011).","journal-title":"Breast Cancer Res. Treat."},{"key":"68522_CR43","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/jbmr.3161","volume":"32","author":"K Stattin","year":"2017","unstructured":"Stattin, K., Michaelsson, K., Larsson, S. C., Wolk, A. & Byberg, L. Leisure-time physical activity and risk of fracture: a cohort study of 66,940 men and women. J. Bone Min. Res. 32, 1599\u20131606 (2017).","journal-title":"J. Bone Min. Res."},{"key":"68522_CR44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bone.2015.06.008","volume":"79","author":"PS Hinton","year":"2015","unstructured":"Hinton, P. S., Nigh, P. & Thyfault, J. Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: a 12-month randomized, clinical trial. Bone 79, 203\u2013212 (2015).","journal-title":"Bone"},{"key":"68522_CR45","doi-asserted-by":"crossref","first-page":"824","DOI":"10.7326\/0003-4819-108-6-824","volume":"108","author":"GP Dalsky","year":"1988","unstructured":"Dalsky, G. P. et al. Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann. Intern. Med. 108, 824\u2013828 (1988).","journal-title":"Ann. Intern. Med."},{"key":"68522_CR46","first-page":"E380","volume":"265","author":"JA Romijn","year":"1993","unstructured":"Romijn, J. A. et al. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am. J. Physiol. 265, E380\u2013E391 (1993).","journal-title":"Am. J. Physiol."},{"key":"68522_CR47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bone.2014.03.044","volume":"64","author":"M Styner","year":"2014","unstructured":"Styner, M. et al. Bone marrow fat accumulation accelerated by high fat diet is suppressed by exercise. Bone 64, 39\u201346 (2014).","journal-title":"Bone"},{"key":"68522_CR48","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ajcn\/79.4.544","volume":"79","author":"BJ Nicklas","year":"2004","unstructured":"Nicklas, B. J. et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am. J. Clin. Nutr. 79, 544\u2013551 (2004).","journal-title":"Am. J. Clin. Nutr."},{"key":"68522_CR49","first-page":"2061","volume":"23","author":"HP Huang","year":"2015","unstructured":"Huang, H. P. et al. Adherence to prescribed exercise time and intensity declines as the exercise program proceeds: findings from women under treatment for breast cancer. Support Care Cancer 23, 2061\u20132071 (2015).","journal-title":"Support Care Cancer"},{"key":"68522_CR50","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3109\/10428194.2014.944519","volume":"56","author":"KK Ness","year":"2015","unstructured":"Ness, K. K. et al. Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia. Leuk. Lymphoma 56, 1004\u20131011 (2015).","journal-title":"Leuk. Lymphoma"},{"key":"68522_CR51","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1200\/JCO.2013.52.2268","volume":"31","author":"KK Ness","year":"2013","unstructured":"Ness, K. K. et al. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study. J. Clin. Oncol. 31, 4496\u20134503 (2013).","journal-title":"J. Clin. Oncol."},{"key":"68522_CR52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0021-9290(99)00210-9","volume":"33","author":"SP Fritton","year":"2000","unstructured":"Fritton, S. P., McLeod, K. J. & Rubin, C. T. Quantifying the strain history of bone: spatial uniformity and self-similarity of low-magnitude strains. J. Biomech. 33, 317\u2013325 (2000).","journal-title":"J. Biomech."},{"key":"68522_CR53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35088122","volume":"412","author":"C Rubin","year":"2001","unstructured":"Rubin, C., Turner, A. S., Bain, S., Mallinckrodt, C. & McLeod, K. Anabolism. Low mechanical signals strengthen long bones. Nature 412, 603\u2013604 (2001).","journal-title":"Nature"},{"key":"68522_CR54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41574-019-0170-1","volume":"15","author":"GM Pagnotti","year":"2019","unstructured":"Pagnotti, G. M. et al. Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity. Nat. Rev. Endocrinol. 15, 339\u2013355 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"68522_CR55","doi-asserted-by":"crossref","first-page":"B352","DOI":"10.1093\/gerona\/54.8.B352","volume":"54","author":"RP Huang","year":"1999","unstructured":"Huang, R. P., Rubin, C. T. & McLeod, K. J. Changes in postural muscle dynamics as a function of age. J. Gerontol. A Biol. Sci. Med. Sci. 54, B352\u2013B357 (1999).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"68522_CR56","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1152\/japplphysiol.01186.2004","volume":"99","author":"CI Morse","year":"2005","unstructured":"Morse, C. I., Thom, J. M., Reeves, N. D., Birch, K. M. & Narici, M. V. In vivo physiological cross-sectional area and specific force are reduced in the gastrocnemius of elderly men. J. Appl. Physiol. 99, 1050\u20131055 (2005).","journal-title":"J. Appl. Physiol."},{"key":"68522_CR57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bone.2012.05.004","volume":"51","author":"GM Pagnotti","year":"2012","unstructured":"Pagnotti, G. M. et al. Low magnitude mechanical signals mitigate osteopenia without compromising longevity in an aged murine model of spontaneous granulosa cell ovarian cancer. Bone 51, 570\u2013577 (2012).","journal-title":"Bone"},{"key":"68522_CR58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bone.2016.05.014","volume":"90","author":"GM Pagnotti","year":"2016","unstructured":"Pagnotti, G. M. et al. Low intensity vibration mitigates tumor progression and protects bone quantity and quality in a murine model of myeloma. Bone 90, 69\u201379 (2016).","journal-title":"Bone"},{"key":"68522_CR59","doi-asserted-by":"publisher","unstructured":"van Heuvelen, M. J. G. et al. Reporting guidelines for whole-body vibration studies in humans, animals and cell cultures: a consensus statement from an international group of experts. Biology https:\/\/doi.org\/10.3390\/biology10100965 (2021).","DOI":"10.3390\/biology10100965"},{"key":"68522_CR60","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/oby.21958","volume":"25","author":"VS Patel","year":"2017","unstructured":"Patel, V. S. et al. Incorporating refractory period in mechanical stimulation mitigates obesity-induced adipose tissue dysfunction in adult mice. Obesity 25, 1745\u20131753 (2017).","journal-title":"Obesity"},{"key":"68522_CR61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1359\/jbmr.080817","volume":"24","author":"YK Luu","year":"2009","unstructured":"Luu, Y. K. et al. Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary-induced obesity. J. Bone Min. Res. 24, 50\u201361 (2009).","journal-title":"J. Bone Min. Res."},{"key":"68522_CR62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1152\/japplphysiol.01020.2014","volume":"119","author":"DM Frechette","year":"2015","unstructured":"Frechette, D. M., Krishnamoorthy, D., Adler, B. J., Chan, M. E. & Rubin, C. T. Diminished satellite cells and elevated adipogenic gene expression in muscle as caused by ovariectomy are averted by low-magnitude mechanical signals. J. Appl. Physiol. 119, 27\u201336 (2015).","journal-title":"J. Appl. Physiol."},{"key":"68522_CR63","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/stem.2004","volume":"33","author":"G Uzer","year":"2015","unstructured":"Uzer, G. et al. Cell mechanosensitivity to extremely low-magnitude signals is enabled by a LINCed nucleus. Stem Cells 33, 2063\u20132076 (2015).","journal-title":"Stem Cells"},{"key":"68522_CR64","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/stem.2342","volume":"34","author":"G Uzer","year":"2016","unstructured":"Uzer, G., Fuchs, R. K., Rubin, J. & Thompson, W. R. Concise review: plasma and nuclear membranes convey mechanical information to regulate mesenchymal stem cell lineage. Stem Cells 34, 1455\u20131463 (2016).","journal-title":"Stem Cells"},{"key":"68522_CR65","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jbiomech.2010.11.022","volume":"44","author":"B Sen","year":"2011","unstructured":"Sen, B. et al. Mechanical signal influence on mesenchymal stem cell fate is enhanced by incorporation of refractory periods into the loading regimen. J. Biomech. 44, 593\u2013599 (2011).","journal-title":"J. Biomech."},{"key":"68522_CR66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41413-020-00111-3","volume":"8","author":"X Yi","year":"2020","unstructured":"Yi, X. et al. Mechanical suppression of breast cancer cell invasion and paracrine signaling to osteoclasts requires nucleo-cytoskeletal connectivity. Bone Res. 8, 40 (2020).","journal-title":"Bone Res."},{"key":"68522_CR67","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1359\/jbmr.060612","volume":"21","author":"V Gilsanz","year":"2006","unstructured":"Gilsanz, V. et al. Low-level, high-frequency mechanical signals enhance musculoskeletal development of young women with low BMD. J. Bone Min. Res. 21, 1464\u20131474 (2006).","journal-title":"J. Bone Min. Res."},{"key":"68522_CR68","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-016-3851-9","volume":"28","author":"AD DiVasta","year":"2017","unstructured":"DiVasta, A. D. et al. The ability of low-magnitude mechanical signals to normalize bone turnover in adolescents hospitalized for anorexia nervosa. Osteoporos. Int. 28, 1255\u20131263 (2017).","journal-title":"Osteoporos. Int."},{"key":"68522_CR69","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/BPO.0b013e3181efbabc","volume":"30","author":"TA Wren","year":"2010","unstructured":"Wren, T. A. et al. Effect of high-frequency, low-magnitude vibration on bone and muscle in children with cerebral palsy. J. Pediatr. Orthop. 30, 732\u2013738 (2010).","journal-title":"J. Pediatr. Orthop."},{"key":"68522_CR70","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1001\/jamaoncol.2015.6557","volume":"2","author":"RJ Mogil","year":"2016","unstructured":"Mogil, R. J. et al. Effect of low-magnitude, high-frequency mechanical stimulation on BMD among young childhood cancer survivors: a randomized clinical trial. JAMA Oncol. 2, 908\u2013914 (2016).","journal-title":"JAMA Oncol."},{"key":"68522_CR71","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.18632\/oncotarget.14139","volume":"8","author":"LE Wright","year":"2017","unstructured":"Wright, L. E. et al. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo. Oncotarget 8, 8406\u20138419 (2017).","journal-title":"Oncotarget"},{"key":"68522_CR72","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/annonc\/mdr356","volume":"23","author":"B Bouvard","year":"2012","unstructured":"Bouvard, B. et al. High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy. Ann. Oncol. 23, 1151\u20131156 (2012).","journal-title":"Ann. Oncol."},{"key":"68522_CR73","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/GME.0000000000000515","volume":"23","author":"P Villa","year":"2016","unstructured":"Villa, P. et al. Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer. Menopause 23, 33\u201339 (2016).","journal-title":"Menopause"},{"key":"68522_CR74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrc3920","volume":"15","author":"CX Ma","year":"2015","unstructured":"Ma, C. X., Reinert, T., Chmielewska, I. & Ellis, M. J. Mechanisms of aromatase inhibitor resistance. Nat. Rev. Cancer 15, 261\u2013275 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"68522_CR75","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1152\/ajpregu.00499.2011","volume":"303","author":"S Gupta","year":"2012","unstructured":"Gupta, S., Vijayaraghavan, S., Uzer, G. & Judex, S. Multiple exposures to unloading decrease bone\u2019s responsivity but compound skeletal losses in C57BL\/6 mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R159\u2013R167 (2012).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"68522_CR76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0891-5849(03)00186-2","volume":"35","author":"JM Lawler","year":"2003","unstructured":"Lawler, J. M., Song, W. & Demaree, S. R. Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle. Free Radic. Biol. Med. 35, 9\u201316 (2003).","journal-title":"Free Radic. Biol. Med."},{"key":"68522_CR77","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2014.05.009","volume":"67","author":"E Ozcivici","year":"2014","unstructured":"Ozcivici, E. & Judex, S. Trabecular bone recovers from mechanical unloading primarily by restoring its mechanical function rather than its morphology. Bone 67, 122\u2013129 (2014).","journal-title":"Bone"},{"key":"68522_CR78","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1152\/japplphysiol.00846.2011","volume":"111","author":"N Holguin","year":"2011","unstructured":"Holguin, N., Uzer, G., Chiang, F. P., Rubin, C. & Judex, S. Brief daily exposure to low-intensity vibration mitigates the degradation of the intervertebral disc in a frequency-specific manner. J. Appl. Physiol. 111, 1846\u20131853 (2011).","journal-title":"J. Appl. Physiol."},{"key":"68522_CR79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10549-018-4924-6","volume":"172","author":"TJ Ballinger","year":"2018","unstructured":"Ballinger, T. J. et al. Impact of primary breast cancer therapy on energetic capacity and body composition. Breast Cancer Res. Treat. 172, 445\u2013452 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"68522_CR80","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ncb3578","volume":"19","author":"DF Quail","year":"2017","unstructured":"Quail, D. F. et al. Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nat. Cell Biol. 19, 974\u2013987 (2017).","journal-title":"Nat. Cell Biol."},{"key":"68522_CR81","doi-asserted-by":"crossref","unstructured":"Iyengar, N. M. et al. Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of a randomized clinical trial and observational study. JAMA Oncol. 5, 155\u2013163 (2019).","DOI":"10.1001\/jamaoncol.2018.5327"},{"key":"68522_CR82","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DS Chan","year":"2014","unstructured":"Chan, D. S. et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann. Oncol. 25, 1901\u20131914 (2014).","journal-title":"Ann. Oncol."},{"key":"68522_CR83","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579\u2013591 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"68522_CR84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0163-7827(01)00024-8","volume":"41","author":"S Eaton","year":"2002","unstructured":"Eaton, S. Control of mitochondrial beta-oxidation flux. Prog. Lipid Res. 41, 197\u2013239 (2002).","journal-title":"Prog. Lipid Res."},{"key":"68522_CR85","first-page":"E409","volume":"238","author":"CL Hoppel","year":"1980","unstructured":"Hoppel, C. L. & Genuth, S. M. Carnitine metabolism in normal-weight and obese human subjects during fasting. Am. J. Physiol. 238, E409\u2013E415 (1980).","journal-title":"Am. J. Physiol."},{"key":"68522_CR86","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/oby.2009.510","volume":"18","author":"SJ Mihalik","year":"2010","unstructured":"Mihalik, S. J. et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18, 1695\u20131700 (2010).","journal-title":"Obesity"},{"key":"68522_CR87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2217\/clp.10.4","volume":"5","author":"CJ Markopoulos","year":"2010","unstructured":"Markopoulos, C. J., Tsaroucha, A. K. & Gogas, H. J. Effect of aromatase inhibitors on the lipid profile of postmenopausal breast cancer patients. Clin. Lipido. 5, 245\u2013254 (2010).","journal-title":"Clin. Lipido."},{"key":"68522_CR88","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1158\/0008-5472.CAN-15-3199","volume":"76","author":"Y Lu","year":"2016","unstructured":"Lu, Y. et al. Acetylcarnitine is a candidate diagnostic and prognostic biomarker of hepatocellular carcinoma. Cancer Res. 76, 2912\u20132920 (2016).","journal-title":"Cancer Res."},{"key":"68522_CR89","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0006-291X(89)91360-0","volume":"161","author":"M Costell","year":"1989","unstructured":"Costell, M., O\u2019Connor, J. E. & Grisolia, S. Age-dependent decrease of carnitine content in muscle of mice and humans. Biochem. Biophys. Res. Commun. 161, 1135\u20131143 (1989).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"68522_CR90","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12944-018-0887-1","volume":"17","author":"M Kang","year":"2018","unstructured":"Kang, M., Yoo, H. J., Kim, M., Kim, M. & Lee, J. H. Metabolomics identifies increases in the acylcarnitine profiles in the plasma of overweight subjects in response to mild weight loss: a randomized, controlled design study. Lipids Health Dis. 17, 237 (2018).","journal-title":"Lipids Health Dis."},{"key":"68522_CR91","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1074\/jbc.M005567200","volume":"276","author":"JB Hansen","year":"2001","unstructured":"Hansen, J. B. et al. Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J. Biol. Chem. 276, 3175\u20133182 (2001).","journal-title":"J. Biol. Chem."},{"key":"68522_CR92","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.bbabio.2007.07.001","volume":"1767","author":"N van Vlies","year":"2007","unstructured":"van Vlies, N., Ferdinandusse, S., Turkenburg, M., Wanders, R. J. & Vaz, F. M. PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim. Biophys. Acta 1767, 1134\u20131142 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"68522_CR93","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1210\/en.2008-0687","volume":"149","author":"B Sen","year":"2008","unstructured":"Sen, B. et al. Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable beta-catenin signal. Endocrinology 149, 6065\u20136075 (2008).","journal-title":"Endocrinology"},{"key":"68522_CR94","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ijo.2009.240","volume":"34","author":"YK Luu","year":"2010","unstructured":"Luu, Y. K. et al. Development of diet-induced fatty liver disease in the aging mouse is suppressed by brief daily exposure to low-magnitude mechanical signals. Int. J. Obes. 34, 401\u2013405 (2010).","journal-title":"Int. J. Obes."},{"key":"68522_CR95","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00198-015-3289-5","volume":"27","author":"D Krishnamoorthy","year":"2016","unstructured":"Krishnamoorthy, D. et al. Marrow adipogenesis and bone loss that parallels estrogen deficiency is slowed by low-intensity mechanical signals. Osteoporos. Int. 27, 747\u2013756 (2016).","journal-title":"Osteoporos. Int."},{"key":"68522_CR96","first-page":"132","volume":"6","author":"YK Luu","year":"2009","unstructured":"Luu, Y. K., Pessin, J. E., Judex, S., Rubin, J. & Rubin, C. T. Mechanical signals as a non-invasive means to influence mesenchymal stem cell fate, promoting bone and suppressing the fat phenotype. Bonekey Osteovision 6, 132\u2013149 (2009).","journal-title":"Bonekey Osteovision"},{"key":"68522_CR97","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1002\/art.24907","volume":"60","author":"T Yamada","year":"2009","unstructured":"Yamada, T. et al. Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis. Arthritis Rheum. 60, 3280\u20133289 (2009).","journal-title":"Arthritis Rheum."},{"key":"68522_CR98","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-411619-1.00007-0","volume":"537","author":"EL Scheller","year":"2014","unstructured":"Scheller, E. L. et al. Use of osmium tetroxide staining with microcomputerized tomography to visualize and quantify bone marrow adipose tissue in vivo. Methods Enzymol. 537, 123\u2013139 (2014).","journal-title":"Methods Enzymol."},{"key":"68522_CR99","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nm995","volume":"10","author":"J An","year":"2004","unstructured":"An, J. et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10, 268\u2013274 (2004).","journal-title":"Nat. Med."},{"key":"68522_CR100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1172\/JCI19574","volume":"113","author":"JY Wu","year":"2004","unstructured":"Wu, J. Y. et al. ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. J. Clin. Invest. 113, 434\u2013440 (2004).","journal-title":"J. Clin. Invest."},{"key":"68522_CR101","doi-asserted-by":"crossref","first-page":"22342","DOI":"10.1074\/jbc.M604350200","volume":"281","author":"MV Jensen","year":"2006","unstructured":"Jensen, M. V. et al. Compensatory responses to pyruvate carboxylase suppression in islet beta-cells. Preservation of glucose-stimulated insulin secretion. J. Biol. Chem. 281, 22342\u201322351 (2006).","journal-title":"J. Biol. Chem."},{"key":"68522_CR102","doi-asserted-by":"crossref","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia, J., Psychogios, N., Young, N. & Wishart, D. S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37, W652\u2013W660 (2009).","journal-title":"Nucleic Acids Res."},{"key":"68522_CR103","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia, J. & Wishart, D. S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 6, 743\u2013760 (2011).","journal-title":"Nat. Protoc."},{"key":"68522_CR104","doi-asserted-by":"crossref","first-page":"W127","DOI":"10.1093\/nar\/gks374","volume":"40","author":"J Xia","year":"2012","unstructured":"Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D. & Wishart, D. S. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40, W127\u2013W133 (2012).","journal-title":"Nucleic Acids Res."},{"key":"68522_CR105","doi-asserted-by":"crossref","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","volume":"44","author":"M Sud","year":"2016","unstructured":"Sud, M. et al. Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 44, D463\u2013D470 (2016).","journal-title":"Nucleic Acids Res."},{"key":"68522_CR106","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116\u20135121 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68522-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68522-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68522-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:02:08Z","timestamp":1771426928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68522-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68522"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68522-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: Dr.\u00a0Clinton T. Rubin is a founder of Marodyne Medical, LLC\u00a0and Lahara Bio, LLC\u00a0and has several patents issued and pending related to the ability of mechanical signals to control musculoskeletal and metabolic disorders.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1808"}}